Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$530M |
| 2 |
AbbVie
ABBV
|
+$429M |
| 3 |
Boston Scientific
BSX
|
+$292M |
| 4 |
Snap
SNAP
|
+$241M |
| 5 |
Royalty Pharma
RPRX
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$327M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$295M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$294M |
| 4 |
Sysco
SYY
|
+$209M |
| 5 |
Shopify
SHOP
|
+$176M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.81% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Arrowhead Research
ARWR
$12.1B
| $40.1M | 0.02% |
+927,799
| New | +$32.7M |
|
552
Cedar Fair
FUN
$1.91B
| $40M | 0.02% |
1,456,183
-2,251,932
| -61% | -$64.1M |
|
553
MGIC Investment
MTG
$6.47B
| $39.7M | 0.02% |
4,849,275
+485,831
| +11% | +$3.63M |
|
554
Colgate-Palmolive
CL
$74.2B
| $39.7M | 0.02% |
541,856
+134,664
| +33% | +$9.57M |
|
555
Mondelez International
MDLZ
$80.2B
| $39.6M | 0.02% |
774,844
-38,919
| -5% | -$2M |
|
556
Ambarella
AMBA
$3.03B
| $39.5M | 0.02% |
861,456
| – | – |
|
557
Vir Biotechnology
VIR
$1.49B
| $38.9M | 0.02% |
+950,310
| New | +$31.9M |
|
|
NLSN
558
DELISTED
Nielsen Holdings plc
NLSN
| $38.3M | 0.02% |
2,576,923
+1,364,180
| +112% | +$19.1M |
|
|
EVBG
559
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $38M | 0.02% |
274,904
-40,271
| -13% | -$5.23M |
|
560
ZTO Express
ZTO
$18.2B
| $37.5M | 0.02% |
1,021,767
-44,909
| -4% | -$1.43M |
|
561
Marcus & Millichap
MMI
$1.2B
| $37.4M | 0.02% |
1,297,533
+217,459
| +20% | +$6.13M |
|
562
FB Financial Corp
FBK
$2.98B
| $37.4M | 0.02% |
1,508,434
+33,096
| +2% | +$737K |
|
563
Yum China
YUMC
$15.6B
| $37.2M | 0.02% |
774,822
+711,183
| +1,118% | +$33.5M |
|
564
Exelon
EXC
$48.4B
| $36.9M | 0.02% |
1,425,066
-518,646
| -27% | -$13.8M |
|
565
Invesco QQQ Trust
QQQ
$445B
| $36.8M | 0.02% |
148,760
+58,637
| +65% | +$13.1M |
|
566
Aprea Therapeutics
APRE
$7.6M
| $36.6M | 0.02% |
47,230
-13,980
| -23% | -$9.17M |
|
567
Novanta
NOVT
$5.04B
| $36.6M | 0.02% |
342,817
-35,819
| -9% | -$3.33M |
|
|
EV
568
DELISTED
Eaton Vance Corp.
EV
| $36.4M | 0.02% |
942,469
-644,073
| -41% | -$23.4M |
|
569
Health Catalyst
HCAT
$158M
| $36.1M | 0.02% |
1,235,986
+57,282
| +5% | +$1.58M |
|
570
Weyerhaeuser
WY
$17.7B
| $35.8M | 0.02% |
1,595,909
+752,479
| +89% | +$15.2M |
|
|
ECOM
571
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $35.5M | 0.02% |
2,239,210
+458,000
| +26% | +$5.29M |
|
572
RLI Corp
RLI
$5.97B
| $35.5M | 0.02% |
863,690
+53,082
| +7% | +$2.09M |
|
573
Digital Realty Trust
DLR
$71.5B
| $35.1M | 0.02% |
246,656
+168,819
| +217% | +$23.9M |
|
574
Newell Brands
NWL
$2.24B
| $34.9M | 0.02% |
2,198,906
+1,171,377
| +114% | +$16.1M |
|
575
Skyworks Solutions
SWKS
$9.73B
| $34.9M | 0.02% |
272,893
-399,943
| -59% | -$44.3M |
|
Similar funds
Janus Henderson Group's Q2 2020 Portfolio in Review
As of Q2 2020, Janus Henderson Group held 1,423 positions worth $178B, up 23% from $145B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2020 filing shows 132 new, 511 increased, 643 reduced and 125 closed positions. Its largest new stake was Royalty Pharma: 4,507,138 shares worth $219M. The largest sale was Boeing, an estimated $327M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2020 buy was Royalty Pharma: 4,507,138 shares worth $219M.
- Janus Henderson Group added most to T-Mobile US in Q2 2020, an estimated $530M increase.
- Janus Henderson Group's biggest Q2 2020 reduction was Boeing, cutting an estimated $327M.
- Janus Henderson Group fully exited Allergan plc in Q2 2020, selling an estimated $128M.
- Janus Henderson Group's ten largest holdings make up 23% of its $178B portfolio in Q2 2020.
- Janus Henderson Group opened 132 new positions and closed 125 in Q2 2020.
- Janus Henderson Group's portfolio value rose 23% quarter-over-quarter to $178B.
Based on Janus Henderson Group's 13F filing for Q2 2020, filed 14 Aug 2020.